EPD041 | Using qualitative feedback from end-users in mhealth application development: differentiated HIV service delivery for anti-retro viral drug refills in Uganda | E-poster | Qualitative and ethnographic methods in HIV research |
EPE338 | Using routinely collected blood donation data for expanded HIV and syphilis surveillance in Blantyre District, Malawi | E-poster | Innovative uses of data to strengthen systems and programmes |
PESUD26 | Using technology to increase STI/HIV case finding through pharmacies in Cambodia | Poster exhibition | Community-based approaches (including empowerment, outreach and service delivery) |
EPF118 | Using the beauty pageant to fight HIV stigma and discrimination in Uganda | E-poster | Discrimination and key populations |
EPE438 | Using the mobile clinic strategy to provide HIV prevention, testing and treatment services in the community during the COVID-19 lock down in Uganda | E-poster | Optimizing HIV services (prevention, testing and/or treatment) in the COVID-19 era |
OAE0503 | Using the RE-AIM framework to evaluate the implementation and effectiveness of a WHO HEARTS based implementation strategy to integrate the management of hypertension into HIV care in Uganda | Oral abstract session with live Q&A | Scaling up access to models of integrated services (HIV, hepatitis, STI and other services, such as harm reduction, SRHR, gender affirming care, TB, NCDs and mental health) |
EPE353 | Using the service quality assessment tool as a strategy to advance pediatric and adolescent HIV services progress towards the 95 95 95 goals for Uganda | E-poster | Approaches to using data to improve programming |
OAC0304 | Using two-stage inverse probability weights to correct mortality estimates for LTFU among children, adolescents and young adults living with HIV in Southern Africa: results from linkage and multi-country tracing studies | Oral abstract session with live Q&A | Monitoring and evaluation of health systems along the HIV cascade |
EPD268 | Utilization of harm reduction services following nonfatal overdose events during the COVID-19 pandemic in the United States: results from a cohort study of overdose survivors | E-poster | Harm reduction |
EPC332 | Utilization of oral pre-exposure prophylaxis (PrEP) after FTC/TAF approval in the United States' | E-poster | Measuring and enhancing retention and adherence in HIV prevention programmes |